chrisvoncsefalvay/vaers-outcomes huggingface dataset:
3/12 2021. Swollen Glands located under chin, over thyroid. Dr ordered sonogram of thyroid results negative. 3/30/ 0201 scheduled 2nd shot woke up with fever over 102. Had fever for 5 days spiked over 103, nurse friend cared for me. Was delirious, have few memories of this time, lost 14 lbs i n 2 weeks. lost appetite.  When i did eat did NOT lose sense of taste or smell just didn't like food. Need guidance on receiving 2nd shot
The pt developed low grade fever of 99.6 deg. F. day after vaccine administration. Also presented with a hot swollen arm with an area of erythema approx. 3 inches in diameter to upper lateral left arm.
A report received from a health professional on 10/28/2002, concerning a 52 year old female vaccinee who received 2 doses of the influenza vaccine (one Fluvirin, one Brand unknown) on 10/26/02. On 10/26/2002, the vaccinee went to 2 separate clinics and received 2 separate doses of the Fluvirin vaccination with the intent of receiving greater immunogenic protection from the vaccine. No adverse reaction was reported. There was insufficient information to determine the reporter's causality assessment.
nosebleed; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (nosebleed) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EPISTAXIS (nosebleed). At the time of the report, EPISTAXIS (nosebleed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.
Patient given expired rabies (IMOVAX) vaccine. Patient with slight arm discomfort one day after vaccinations given on 10/30/2018.
intense mood swings/crying out of nowhere all day, 2 days following the vaccine. this happened with my second shot as well, but on a more minor scale.  not normal at all for me.
After receiving immunization, she was asked to wait 15 min for any adverse reactions. After 13 min of receiving flu shot, customer felt  stomach upsetting, dizziness and weakness. Pharmacist in charge called 911 and remained by customer side until ambulance arrived the store at 11:46am. Paramedics assessed her and left after she was stabilized. Customer was not taken in the ambulance.
When lying down to sleep, patient began to twitch intermittently across his upper body. He also said it felt like he was being bitten by a mosquito at the area where he was twitching.
pt recv vax 18APR95 & pt devel a rash resembling vasculitis or panniculitis;No further details were provided;
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Pertinent medical history, drug reactions or allergies were not reported. On 29-SEP-2014, the patient was vaccinated with an expired opened dose of PNEUMOVAX 23 lot # J009827, expiry date: 10-AUG-2014 (dose and route were not reported). The pharmacist also stated that from 10-AUG-2014 through 10-SEP-2014, the opened vial of PNEUMOVAX 23 was previously exposed to 70F. No adverse symptoms reported. This is one of three cases from the same reporter. Additional information has been requested.
Patient broke out in hives after vaccines given - 2/15/2010 - per mom (1 day after vaccines) - ROTATEQ, DTAP, IPV, Hib, PREVNAR. The hives went away in 1 day. On 4/16/2010 - patient received ROTATEQ, DTAP, Hib, PREVNAR. Eight minutes later, he broke out in a splotchy rash in the office. We gave BENADRYL and the rash almost completely subsided.
Pt had onset of sneezing followed by rash that progressed for 3 days from upper body to extremities -papules with petechial component-minimal pruritis, pt never febrile perssited > 6 wks.
she receieved the moderna covid vaccine 1st dose, she waited in the chair and about 15 minutes then she came and said her left arm from hand up to elbow was numb and tingling. no pain at injection site. she also said she felt a little nauseated, she got something to drink and then said she was feeling better. A couple hours later she called the pharmacy saying her arm was still numb (just from had to elbow). She said thee no pain or numbness in upper part of arm where she gto the shot.
No additional adverse events reported; Medical Assistant reports the administration of improperly stored vaccine.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies were not reported.  On 25-AUG-2022, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5 mL (lot # W016358, expiration date: 16-NOV-2023) (dose, route of administration and anatomical location not provided) for prophylaxis. The vaccine underwent a temperature of -13.4 degrees Celsius (°C) during a time frame of 45 minutes. Moreover, it was reported that had previous temperature excursions between -14°C up to -10°C (-10.4°C) for 5 hours. No additional adverse event was reported. No further details provided.
had 2 episodes witnessed 1st occurred 2 days p/vax & 2nd 2 wk p/vax each occurred 5-10min p/vax;lasted 5sec pt arched head & body back & became stiff, jerked arms;fell asleep did  not try to arouse so np post ictal
Chills, Fever, Aches, Migraines, muscle soreness, pain in injected arm, Dizziness, Nausea, tiredness
Information has been received from a registered nurse concerning a patient who on an unspecified date during a several week interval in June and July 2010, was vaccinated with a dose of PNEUMOVAX 23 (lot#666639/0564Z). Subsequently, the patient developed a case of cellulitis centered on the injection site. The patient was treated with antibiotics. At the time of this report. the patient's outcome was not reported. This is one of several reports from the same source. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
Arm was itchy at the injection site; Arm was red at the injection site; Sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Arm was itchy at the injection site), VACCINATION SITE ERYTHEMA (Arm was red at the injection site) and VACCINATION SITE PAIN (Sore) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Arm was itchy at the injection site), VACCINATION SITE ERYTHEMA (Arm was red at the injection site) and VACCINATION SITE PAIN (Sore). At the time of the report, VACCINATION SITE PRURITUS (Arm was itchy at the injection site), VACCINATION SITE ERYTHEMA (Arm was red at the injection site) and VACCINATION SITE PAIN (Sore) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications not reported Treatment medications were not provided
I got covid Jan 3rd, that progressed to pneumonia in my left lung by Jan 26
Patient with swelling, induration, warmth and ,mild erythema of left thigh.
Visual changes after AVA 1 and 2.  AVA 1 had black vision X 3-6 sec with needle injection.  1 hr later c/o difficult focusing on letters/numbers being unable to see clearly.  Had to squint and concentrate hard to interpret.  C/O photophobia.  He denied any blurring or diff seeing colors, objects, etc just reading.  Eyes seems red and itched.  No HA, dizziness, URI or other s/s with AVA.  Vision remained out of focus for 3 wks and then he seems use to it.  AVA 2 had same s/s with c/o frontal HA 8/10 for 3 days, which has resolved.  His light sensitivity is worse needing sun glasses when outside and flourscent lights bother him.  He does have PATENOL for itchy eyes used mainly in Jun/July due to cactus and other desert flowers blooming.
Covid arm - warm, itchy red lump at site of covid shot 8 days after vaccine.
10 days after receiving developed severe planter fasciitis. Still suffering from it. 11 months already! Been to 2 podiatrists, mri confirmed. Received 2 cortisone injections. Debilitating!
This case was reported by a pharmacist via call center representative and described the occurrence of erythema of extremities in a 67-year-old female patient who received SHINGRIX. Concurrent medical conditions included diabetes and penicillin allergy. On 10th March 2018, the patient received the 1st dose of SHINGRIX. On 10th March 2018, less than a day after receiving SHINGRIX, the patient experienced erythema of extremities, swelling arm, feeling of warmth and pain in arm. On an unknown date, the outcome of the erythema of extremities, swelling arm, feeling of warmth and pain in arm were recovering/resolving. It was unknown if the reporter considered the erythema of extremities, swelling arm, feeling of warmth and pain in arm to be related to SHINGRIX. Additional information was reported as follows: The reporting pharmacist stated that the patient received no other vaccines within four weeks prior to receiving SHINGRIX. The reporting pharmacist stated that the patient was currently on insulin and blood pressure medications, but did not know which specific medications at time of call due to being out of facility. The patient received her SHINGRIX in the right deltoid and experienced pain, redness, and warmth on her right arm at the night of administration. The redness was smaller than a baseball on her arm. The reporting pharmacist stated that she was not aware of any medical intervention taken because of patient's reactions. The reporting pharmacist stated she believed the symptoms were related to SHINGRIX. The reporting pharmacist did not have lot number or expiration at time of reporting.
Pt received HPV (GARDASIL) #2 in L deltoid. Here for TI DM follow-up, not acutely ill. Within < 1 min, pt c/o pain, and erythema noted. I was called in. Within < 3 mins, pt developed urticaria that spread from L deltoid to shoulders - to R arm. No SOB/wheezing or throat symptoms. Gave BENADRYL 50 mg and XYZAL 5 mg - decrease urticaria and decrease deltoid edema.
Pt reports starting to feel tender around 8pm the night she received vaccines. Later that night and the next morning she developed body aches, joint swelling, swollen glands, sore throat with mild swelling, mild fever, red spots on body, vomiting. Tx with diphenhydramine, changed antibiotic pt was using, given vicodin for pain.
Breakthrough case admission after three vaccines 4/12/21 Lot# 030B21A no manufacturer;  Moderna 5/10/21 Lot# 043B21A;  Moderna 12/14/21 Lot# 067H21A
I felt tightness in my chest and had green mucas deep down in my chest as if I had a flu or cold.  I could not cough it up on my own.  I used my nebulizer with albuterol to alleviate the tightness in the chest and help loosen and expel the mucas.  If this had been allergy related the mucas would not have been so deep in the chest and difficult to expel.
pt recv vax 25SEP95 & DEC95 pt devel a nl case of chickenpox, which was felt to be a vaccine failure;pt recovered;
Drowsy; Not feeling good; Redness on arm; Swelling on arm; This is a spontaneous report from a contactable consumer (patient). A 41-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unknown date at single dose for COVID-19 immunization. Medical history was not reported. Concomitant medication included influenza vaccine (FLU VACCINE VII). The patient had been feeling drowsy and not feeling good. He was experiencing redness and swelling on his arm and he cant pick it up. He can pick it up but not like normal. He got a flu shot same day and went to with held and got Benadryl. The outcome of all events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
After the vaccination I developed a bad headache, nausea, chills and a low grade fever were associated and had muscle and body aches which all lasted about 4 days and subsided.
After i received the flu shot in early Nov 2002, I became nauseous and dizzy. Today is Mon. Dec. 23,2002 and I continue to be nauseous, dizzy and my balance is bad. When I close my eyes, i spin , I also got a severe sinus infection. I was quite and felling very good until I received the flu shot
Felt weak after vaccine admin. 24 hrs later chest pressure, feeling of shortness breath, parasthesias arms, hands, calves. General fatigue persists.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 29Sep2022 as dose 4 (booster), single (Lot number: GH9693) at the age of 35 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing). Concomitant medication(s) included: LABETALOL. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Rebound covid positive with mild symptoms 2 days after testing negative via home rapid antigen test; Negative, notes: Rebound covid positive with mild symptoms 2 days after testing negative via home rapid antigen test. Therapeutic measures were taken as a result of drug ineffective, covid-19 which includes Paxlovid from 08Nov2022 to 12Nov2022.  Additional information: Rebound covid positive with mild symptoms 2 days after testing negative via home rapid antigen test
Heart palpitations, shortness of breath, body aches.  2 days after last dose of vaccine  Still have occasional heart palpitations if I walk to long.
Hiberix reconstituted with steril water; Hiberix reconstituted with steril water administeration; This case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 15-month-old male patient who received Hib (Hiberix) (batch number FY4E9, expiry date 20th June 2023) for prophylaxis.   On 3rd October 2022, the patient received Hiberix. On 3rd October 2022, unknown after receiving Hiberix, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 10-Oct-2022 Reporter's Comment: The reporter reported that, a patient received the lyophilized powder of Hiberix reconstituted with diluent not provided by GlaxoSmithKline (sterile water). The reporter consent to follow up. Additional Supportive Information: The patient received Hiberix vaccines reconstituted with sterile water which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. This case is linked to the case US2022143259, reported by the same reporter.; Sender's Comments:  US-GSK-US2022143259:Same reporter
Patient stated tingling and numbness. EMT transported the patient to hospital ER given Benadryl 50 mg.
little Sore Arm; Pressure on the Chest; could not breath; This spontaneous case was reported by a patient and describes the occurrence of DYSPNOEA (could not breath) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy NOS (Patient is feeling fatigue and tired due to allergies.).    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced DYSPNOEA (could not breath) (seriousness criterion medically significant) and CHEST DISCOMFORT (Pressure on the Chest). On an unknown date, the patient experienced PAIN IN EXTREMITY (little Sore Arm). On 31-Mar-2021, DYSPNOEA (could not breath) and CHEST DISCOMFORT (Pressure on the Chest) had resolved. At the time of the report, PAIN IN EXTREMITY (little Sore Arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This case was reported by a consumer via call center representative and described the occurrence of unexpected therapeutic effect in a female patient who received SHINGRIX for prophylaxis. The patient's past medical history included neuropathy peripheral (peripheral neuropathy on the suboccipital neuralgia), pneumonia and shingles. Previously administered products included antidepressant, opioids, calcium channel drugs and SHINGRIX with an associated reaction of therapeutic response unexpected (refer case: US2018131406). Concurrent medical conditions included pain. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced unexpected therapeutic effect. On an unknown date, the outcome of the unexpected therapeutic effect was unknown. It was unknown if the reporter considered the unexpected therapeutic effect to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient's father. The age at vaccination was not reported. The patient had pneumonia and all the sudden she started having Peripheral Neuropathy (PHN) on the suboccipital neuralgia. Investigating physician was suspecting that it was PHN related to the shingles. Even though the patient did not get a rash, physician believes she had symptoms that were related to PHN due to shingles. At the time of this report, the physician was investigating the cause. The patient had been on opioids, antidepressant, calcium channel drugs and all sort of drugs to treat her pain and the reporter had been struggling with that for 5 years. The patient had SHINGRIX injection three months afterwards from the 1st dose of SHINGRIX and the patient's pain went away for full 48 hours. And then it came back. The reporter wanted to let the company know, that it could be worth investigating using SHINGRIX vaccine for other indications. This case has been linked to the US2018131406, reported by the same reporter.
Starte 3 hrs post injection burning, redness, progression to all over hives, itching-Tx with BENADRYL 3 days, prednisone 3 day, PROVENTIL inhaler.
Patient presents to the ICC with complaints of chest tightness and  heart racing that started a few minutes after getting her first dose of Pfizer Covid vaccine yesterday.  Patient states she continues to have symptoms and is here to get checked. Patient denies a past history of cardiac disease, she has had a stress test in the past and was negative. Patient denies dizziness, headache, syncope or leg swelling.
25 y.o. male w/Reax to smallpox vax. Diffused papular rash w/vesicles to entire body. Dizziness, fatigue. No itchiness. Possible reaction to vaccinia, op site on amoxicillin v/s viral exanthema. MEDS: Ranitidine, Benadryl.
The above vaccine was administered after the "Use By" date as assigned after it was removed from the freezer.
2mo w/inconsolable higher pitch crying & decreased oral intake;no fever vomiting, rashes;duration almost 48hr;@ 48hr crying halted neurological exam nl;
I had two shots and had shingles/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had in 1978). Concurrent medical conditions included diabetes.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had 2 Shingles shots and had shingles twice, in 1978 and at the time of reporting. The patient said watch your stress level and diet especially if you had diabetes. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Patient reports that RUE began to experience numbness shortly after receiving influenza vaccine in her Right Upper Deltoid. Numbness has improved; however, continues to report numbness to tips of two fingers.
A hot spot; It has progressed to an from my shoulder down to elbow with swelling; I noticed redness in the shot area; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (A hot spot), PERIPHERAL SWELLING (It has progressed to an from my shoulder down to elbow with swelling) and VACCINATION SITE ERYTHEMA (I noticed redness in the shot area) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jun-2021, the patient experienced FEELING HOT (A hot spot), PERIPHERAL SWELLING (It has progressed to an from my shoulder down to elbow with swelling) and VACCINATION SITE ERYTHEMA (I noticed redness in the shot area). At the time of the report, FEELING HOT (A hot spot), PERIPHERAL SWELLING (It has progressed to an from my shoulder down to elbow with swelling) and VACCINATION SITE ERYTHEMA (I noticed redness in the shot area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. Treatment information not reported.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: No specific follow-up information recorded.